Delivery Order SPE2DB20D3103-SPE2DB24FM0G5
Award Date
12/21/23
Potential Completion Date
1/16/24
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Medical Supply Chain, a component of the Defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,465.68 firm fixed price delivery order is for the supply of the prescription medication Envarsus XR 1 mg tablets. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,230.68 firm fixed-price delivery order is for the supply of Envarsus XR 4 mg tablets. The contract has a period of performance through June 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,423.90 firm fixed-price delivery order is for the supply of 100 units of Envarsus XR 4 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $1,465.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of Envarsus XR 1 mg tablets in quantities of 30, with a period of performance through April 30, 2024. This is a firm-fixed-price delivery order contract, and there is no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $4,845.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Envarsus XR 4 mg tablets, with a completion date of November 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,230.68 firm fixed-price delivery order is for the drug Envarsus XR 4 mg tablet, with a completion date of November 13, 2024. The award is not associated with a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,099.26, is for the delivery of Envarsus XR 1 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the DLA to...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,465.68, is for the delivery of Envarsus XR 1 mg tablets. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,026.85 firm fixed-price delivery order is for the supply of the pharmaceutical product Envarsus XR 1 mg tablets. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Envarsus XR 1 mg tablets. The contract, valued at $1,465.68, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to serve the Department of Defense (DoD) and other government agencies. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to...